Gulfan, Arbania G.
HRN: 28-01-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFUROXIME 500MG (TAB)
10/29/2025
11/04/2025
PO
500 Mg
BID
UTI Following Delivery
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes